Antimicrobial susceptibility testing

MICRONAUT-S Pseudomonas MIC

MIC values for critically important antibiotics and backup antibiotics used for treatment of infections caused by non-fermenting pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia

Punti salienti

MIC determination of critical important backup antibiotics used for clinically important non-fermenting pathogens

In recent years, there has been a dramatic increase in multi-drug resistance (MDR) amongst gram-negative pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting organisms. This has impacted the treatment of both hospital and community acquired infections. Therefore, accurate and reliable MIC determination is crucial for a successful antimicrobial therapy.

 

The routine MIC plate MICRONAUT-S Pseudomonas MIC provides an extended spectrum of standard and critical important backup antibiotics used for treatment of infections caused by multi-drug resistant non-fermenting pathogens. It enables MIC determination of antibiotics like piperacillin-tazobactam, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, tigecyclin and colistin in a single test run. MIC values are interpreted according to currently valid EUCAST breakpoints.

Caratteristiche

MIC plate for AST of multi-drug resistant non-fermenting bacteria (MDR phenotype)

The MICRONAUT-S Pseudomonas MIC test plate offers a range of features and benefits relating to the phenotypic quantification of MIC values for critically important backup antibiotics used for treatment of bacterial infections caused by non-fermenting bacteria.

  • AST is carried out by broth microdilution method
  • Resistance determination of clinically relevant non-fermenting organisms (Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia and other non-fermenters) against antibiotics and antibiotic combinations
  • AST for highly effective and critically important backup antibiotics and antibiotic combinations like piperacillin-tazobactam, ceftazidime-avibactam, ceftolozane-tazobactam or tigecycline in a single test run
  • Accurate and reliable AST for colistin
  • Analysis and interpretation of MIC values after visual or automated reading according to EUCAST standard

 

Please contact your local representative for availability in your country.

Not for sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)

Maggiori informazioni

Related products

merlin-micronaut-s-title

MICRONAUT-S MRSA GP

Based on the broth microdilution (BMD) procedure, the MICRONAUT-S MRSA/GP system provides the phenotypic detection of clinically relevant single or multi-resistance in staphylococci, enterococci and streptococci organisms. The susceptibility testing with highly effective back up antibiotics like ceftaroline, linezolid, tigecycline, daptomycin, and vancomycin offers therapeutic options in case of multi-drug resistance.
micronaut-s-ß-lactamases-carbapenemases-bruker-merlin-md-web

MICRONAUT-S ß-Lactamases & MICRONAUT-S Carbapenemases Detection

Based on the standard broth microdilution (BMD) method, the MICRONAUT-S ß-Lactamases and MICRONAUT-S Carbapenemases Detection systems are the only broth microdilution based systems that can differentiate between all Ambler class A (ESBL, KPC), class B (MBL), class C (AMP-C) and class D (OXA-48-like) cephalosporinases and / or carbapenemases.
merlin-micronaut-s-title

MICRONAUT-S MDR MRGN-Screening

Based on the standard broth microdilution (BMD) procedure, the antimicrobial susceptibility testing (AST) plate MICRONAUT-S MDR MRGN Screening provides the phenotypic detection of clinically relevant resistance mechanisms, including confirmation of cephalosporinases and carbapenemases in Enterobacterales and non-fermenters.
merlin-micronaut-s anaerobes-title

MICRONAUT-S Anaerobes MIC

Based on the broth microdilution (BMD) procedure, the AST plate MICRONAUT-S Anaerobes MIC provides the tool for phenotypic detection of clinically relevant resistance mechanisms in anaerobic pathogens such as Clostridium spp., Bacteroides spp. and Peptostreptococcus spp.
micronaut-am-bruker-merlin-md-web

MICRONAUT-AM

The increasing prevalence and severity of fungal infections in healthcare scenarios requires a standardized routine antifungal susceptibility test (AFST) in the microbiology lab. The MICRONAUT-AM system uses MIC plates for the automated or manual susceptibility testing of yeast and cryptococci.
merlin-micronaut-s pneumococci and haemophilus mic-penicillin-title

MICRONAUT-S Pneumococci & Haemophilus MIC

Based on the standard broth microdilution (BMD) method, the routine antimicrobial susceptibility testing (AST) plate MICRONAUT-S Pneumococcus & Haemophilus MIC provides the phenotypic quantification of MIC values for 14 different antibiotics and antibiotic combinations commonly used for treatment of infections caused by Streptococcus pneumoniae and Haemophilus influenzae.
mic-strips-bruker-merlin-md-web

BMD MIC-Strips

BMD MIC-Strips are quantitative assays using the broth microdilution method, for determining the minimum inhibitory concentration (MIC) of antimicrobial agents (colistin, piperacillin-tazobactam, vancomycin/teicoplanin) against microorganisms to indicate appropriate patient treatment and for identifying resistance patterns.
merlin-micronaut-s-title

MICRONAUT IVD System

MICRONAUT IVD system offers a range of antibiotic resistance and specialty susceptibility testing
growth-media-bruker-merlin-md-web

Growth Media

For susceptibility testing of microorganisms
software-and-devices-bruker-merlin-md-web

Software and Devices

The software and devices available for using the MICRONAUT systems offer users a flexible degree of automation.